• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

HeartWare International Inc.

Medtronic touts stroke data for HeartWare LVAD

April 5, 2019 By Brad Perriello

A retrospective analysis of two studies involved the HeartWare left-ventricular assist device Medtronic (NYSE:MDT) acquired in 2016 showed that managing blood pressure reduced the severity of strokes in patients implanted with the HVAD pump. The analysis, of “destination therapy” patients who are not candidates for a heart transplant, took data from the Endurance and Endurance […]

Filed Under: Clinical Trials, Featured, Structural Heart Tagged With: Abbott, HeartWare International Inc., Medtronic, stjudemedical, Thoratec Corp.

Medtronic’s HeartWare to settle investor suit for $55m

November 19, 2018 By Brad Perriello

Medtronic (NYSE:MDT) subsidiary HeartWare International agreed to settle a class-action lawsuit brought over a failed trial of its MVAD implantable heart pump. The lawsuit’s origins lie in the July 2015 launch of a clinical trial aimed at winning CE Mark approval in the European Union for HeartWare’s next-generation MVAD pump. The company hit the pause button in September 2015 after running into an issue with […]

Filed Under: Featured, Legal News, Structural Heart, Wall Street Beat Tagged With: HeartWare International Inc., Medtronic

Medtronic’s HeartWare can’t slip investors class action over failed MVAD trial

March 19, 2018 By Brad Perriello

A federal judge in New York City last week shot down a bid by Medtronic subsidiary HeartWare to dismiss a class-action lawsuit brought over a failed trial of its MVAD implantable heart pump. Framingham, Mass.-based HeartWare in July 2015 launched a clinical trial aimed at winning CE Mark approval in the European Union for the next-generation […]

Filed Under: Legal News, Structural Heart, Wall Street Beat Tagged With: HeartWare International Inc., Medtronic

Shockwave Medical picks up ex-HeartWare CEO Godshall | Personnel Moves – May 11, 2017

May 11, 2017 By Fink Densford

Shockwave Medical said today it tapped former HeartWare CEO Doug Godshall as its new prez & CEO. Godshall served as CEO of HeartWare for 10 years until the business was acquired by Medtronic (NYSE:MDT) for $1.1 billion last August, Fremont, Calif.-based Shockwave Medical said. Prior to his time at HeartWare, Godshall held various executive and leadership […]

Filed Under: Business/Financial News Tagged With: Baxter, Biolase, California Life Sciences Association, Elekta, Haemonetics, HeartWare International Inc., Intact Vascular, Personnel Moves, reflexion-health, Repro Med Systems, Shockwave Medical, Titan Spine, Verily

ISHLT 2017: Medtronic HVAD trial misses primary endpoint, reports lowered stroke rates

April 5, 2017 By Fink Densford

Medtronic (NYSE:MDT) said today that results from the Endurance supplemental trial of its HVAD heart pump system did not meet its primary endpoint, but did report  lowered stroke rates compared to standard treatment. The trial aimed to evaluate the use of the HVAD system, which it picked up along with HeartWare last year, as a destination […]

Filed Under: Cardiovascular, Clinical Trials, Structural Heart Tagged With: HeartWare International Inc., Medtronic

Medtronic’s HeartWare launches new HVAD controller, recalls older models

March 20, 2017 By Brad Perriello

The HeartWare subsidiary Medtronic (NYSE:MDT) acquired for $1 billion last year is launching a new controller for its HVAD left ventricular assist devices and recalling older versions of the device. Issues with the implantable heart pump’s controller date back to at least April 2010, when HeartWare said a July 2009 redesign aimed at waterproofing the controllers inadvertently made them […]

Filed Under: Recalls, Structural Heart, Wall Street Beat Tagged With: HeartWare International Inc., Medtronic

Medtronic wins EU nod for less-invasive HVAD implant procedure

November 29, 2016 By Fink Densford

Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union for a less-invasive implant procedure for the HVAD system left ventricular assist device it acquired along with HeartWare in August. The new implantation procedure uses a smaller incision than the previously cleared procedure, Fridley, Minn.-based Medtronic said, potentially lessening bleeding and related […]

Filed Under: Cardiac Implants, Cardiovascular, Regulatory/Compliance, Structural Heart, Surgical Tagged With: HeartWare International Inc., Medtronic

FDA updates on 2 Class I HeartWare HVAD recalls

November 16, 2016 By Fink Densford

Correction: A previous version of this article identified this as a new set of recalls, due to differing product codes and recall counts.  This was incorrect, and updated with information from Medtronic/HeartWare. The FDA today released updated information on Class I recalls for Medtronic‘s (NYSE:MDT) HeartWare Ventricular Assist Devices, affecting a total of 4,669 units. A Class […]

Filed Under: Cardiovascular, Food & Drug Administration (FDA), Recalls, Structural Heart Tagged With: HeartWare International Inc., Medtronic

FDA posts another Class I HeartWare HVAD recall

October 28, 2016 By Fink Densford

The FDA today posted a Class I recall notice for select Medtronic (NYSE:MDT) HeartWare ventricular assist device controllers over issues with loose power connectors that could stop the pump from functioning. A Class 1 indication from the federal watchdog indicates “a reasonable probability that use of these products will cause serious adverse health consequences or death,” according […]

Filed Under: Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Recalls, Structural Heart Tagged With: HeartWare International Inc., Medtronic

Medtronic recalls Heartware HVADs over driveline contamination issues

October 21, 2016 By Fink Densford

The FDA today released a recall notice for Medtronic (NYSE:MDT) subsidiary HeartWare International‘s Heartware Ventricular Assist Device over issues with driveline connector tubes of select units which may cause the pump to stop. The federal watchdog labeled the recall as Class 1, indicating “a reasonable probability that use of these products will cause serious adverse health consequences or […]

Filed Under: Cardiac Implants, Cardiovascular, Recalls, Structural Heart Tagged With: HeartWare International Inc., Medtronic

Medtronic’s HeartWare faces 2 Class I FDA recalls

September 30, 2016 By Fink Densford

Medtronic (NYSE:MDT) said today the FDA labeled 2 outstanding global voluntary recalls related to subsidiary HeartWare International‘s HVAD system as Class 1. A Class 1 indication from the federal watchdog indicates “a reasonable probability that use of these products will cause serious adverse health consequences or death,” according to the agency. The voluntary recall is related […]

Filed Under: Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Structural Heart Tagged With: HeartWare International Inc., Medtronic

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 15
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy